Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
May 7, 2024, 15:45 |
Blog
FDA Oncology's Project 5 in 5
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared a…
May 4, 2024, 10:40 |
Insight
Thor Halfdanarson: Presacral NETs remain a mystery to me
Thor Halfdanarson, Vice President of the North American Neuroendocrine Tumor Society, recently shared on X:…
May 3, 2024, 16:39 |
Insight
Thor Halfdanarson: Cannabis in patients with cancer
Thor Halfdanarson, Medical Oncologist focusing on gastrointestinal malignancies at Mayo Clinic, shared on X/Twitter: "Cannabis…
May 3, 2024, 04:53 |
Blog
Tanja Obradovic: Herceptin biosimilar Hercessi has just been approved by FDA
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on LinkedIn:…
May 2, 2024, 02:53 |
Drugs
FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
FDA Approves the First Radioactive Drug for Pediatric Neuroendocrine Tumors the U.S. Food and Drug…
May 1, 2024, 12:17 |
Insight
David R. Liu: The first prime editing clinical trial has been cleared by U.S. FDA to begin
David R. Liu, Core Institute Member and Vice-Chair of the Faculty at Broad Institute of MIT…
May 1, 2024, 12:12 |
Blog
FDA has cleared Prime Medicine's PM359 for the treatment of chronic granulomatous disease
Prime Medicine shared on X/Twitter: "We are pleased to announce that FDA has cleared our IND…
May 1, 2024, 10:55 |
Blog
Tanja Obradovic: The spotlight of FDA last week
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on LinkedIn:…
May 1, 2024, 10:50 |
Blog
Chris Boshoff: The U.S. FDA granted full approval for our therapy developed with our partner Genmab
Chris Boshoff shared a post on LinkedIn: "Today, the U.S. FDA granted full approval for our…
Apr 29, 2024, 07:58 |
Blog
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
13
14
15
16
17
All:
937
Posts:
141 - 150
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube